MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ymthe.2025.10.010

Медицинская библиотека · Molecular therapy : the journal of the American Society of Gene Therapy · 2025

M2 macrophage exosomes reverse heart failure post-myocardial infarction by suppressing type 1 interferon signaling in myeloid cells.

Ng Martin, Gao Alex S, Phu Tuan Anh, Vu Ngan K, Raffai Robert L

СтатьяПеревод пока не подготовлен

Аннотация

Effective treatment strategies to alleviate heart failure that develops as a consequence of myocardial infarction (MI) remain an unmet need in cardiovascular medicine. In this study, we uncover that exosomes produced by human Tohoku Hospital Pediatrics-1 (THP-1) macrophages cultured with the cytokine interleukin-4 (THP1-IL4-exo) reverse cardiac functional decline in mice that developed MI in response to diet-induced occlusive coronary atherosclerosis. The therapeutic benefits of THP1-IL4-exo stem from their ability to drive transcriptional reprogramming of inflammatory responses in myeloid cells. Notably, repeated infusions of THP1-IL4-exo led to the suppression of type 1 interferon signaling in circulating Ly-6Chi monocytes as well as in myeloid cells within the bone marrow and cardiac tissue. In vitro studies with primary macrophages stimulated with double-stranded DNA confirmed an ability for THP1-IL4-exo to confer suppression of type 1 interferon-mediated immune activation and inflammation. Collectively, these benefits contribute to the control of myelopoiesis, recruitment of cardiac myeloid cells, and preservation of populations of resident cardiac macrophages that together mitigate cardiac inflammation, adverse ventricular remodeling, and heart failure. Our findings introduce THP1-IL4-exo, one form of M2-macrophage exosomes, as novel anti-inflammatory and tissue repair therapeutics to preserve cardiac function post-MI.

Для цитирования: Ng Martin, Gao Alex S, Phu Tuan Anh, Vu Ngan K, Raffai Robert L. M2 macrophage exosomes reverse heart failure post-myocardial infarction by suppressing type 1 interferon signaling in myeloid cells.. Molecular therapy : the journal of the American Society of Gene Therapy. 2025. DOI: 10.1016/j.ymthe.2025.10.010.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.